Functional MRI in the early detection of dementias

Revue Neurologique

Volumn 162, Issue 10, 2006, Pages 941-944

  Dickerson, B C ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Functional magnetic resonance imaging; Mild cognitive impairment

Indexed keywords

BRAIN FUNCTION; COGNITION; CONFERENCE PAPER; DATA ANALYSIS; DEMENTIA; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; MEMORY; TASK PERFORMANCE; WHITE MATTER;

EID: 33749351109     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(06)75103-7     Document Type: Conference Paper

References (38)

1. BONDI MW, HOUSTON WS, EYLER LT, BROWN GG. (2005). fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology, 64: 501-508.
2. BOOKHEIMER SY, STROJWAS MH, COHEN MS et al. (2000). Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med, 343: 450-456.
3. BUCKNER RL, SNYDER AZ, SHANNON BJ et al. (2005). Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci, 25: 7709-7717.
4. CITRON M. (2004). Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci, 5: 677-685.
5. COLEMAN P, FEDEROFF H, KURLAN R. (2004). A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology, 63: 1155-1162.
6. CUMMINGS JL. (2004). Alzheimer's disease. N Engl J Med, 351: 56-67.
7. DICKERSON BC, SPERLING RA. (2005). Neuroimaging Biomarkers for Clinical Trials of Disease-Modifying Therapies in Alzheimer's Disease. Neurorx, 2: 348-360.
8. DICKERSON BC, SALAT DH, BATES JF et al. (2004). Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol, 56: 27-35.
9. DICKERSON BC, SALAT DH, GREVE DN et al. (2005). Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology, 65: 404-411.
10. GRADY CL, MCINTOSH AR, BEIG S, KEIGHTLEY ML, BURIAN H, BLACK SE. (2003). Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J Neurosci, 23: 986-993.
11. GREICIUS MD, SRIVASTAVA G, REISS AL, MENON V. (2004). Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A, 101: 4637-4642.
12. GRON G, BITTNER D, SCHMITZ B, WUNDERLICH AP, RIEPE MW. (2002). Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder. Ann Neurol, 51: 491-498.
13. GROSSMAN M, KOENIG P, DEVITA C et al. (2003a). Neural basis for verb processing in Alzheimer's disease: an fMRI study. Neuropsychology, 17: 658-674.
14. GROSSMAN M, KOENIG P, GLOSSER G et al. (2003b). Neural basis for semantic memory difficulty in Alzheimer's disease: an fMRI study. Brain, 126: 292-311.
15. JOHNSON SC, SAYKIN AJ, BAXTER LC et al. (2000). The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and alzheimer disease. Neuroimage, 11: 179-187.
16. JOHNSON SC, SCHMITZ TW, TRIVEDI MA et al. (2006). The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci, 26: 6069-6076.
17. KATO T, KNOPMAN D, LIU H. (2001). Dissociation of regional activation in mild AD during visual encoding: a functional MRI study. Neurology, 57: 812-816.
18. KUKULL WA, BOWEN JD. (2002). Dementia epidemiology. Med Clin North Am, 86: 573-590.
19. LUSTIG C, SNYDER AZ, BHAKTA M et al. (2003). Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci U S A, 100: 14504-14509.
20. MACHULDA MM, WARD HA, BOROWSKI B et al. (2003). Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology, 61: 500-506.
21. RAICHLE ME, MACLEOD AM, SNYDER AZ, POWERS WJ, GUSNARD DA, SHULMAN GL. (2001). A default mode of brain function. Proc Natl Acad Sci U S A, 98: 676-682.
22. ROMBOUTS SA, BARKHOF F, VAN MEEL CS, SCHELTENS P. (2002). Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatry, 73: 665-671.
23. ROMBOUTS SA, VAN SWIETEN JC, PIJNENBURG YA, GOEKOOP R, BARKHOF F, SCHELTENS P. (2003). Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD. Neurology, 60: 1904-1908.
24. ROMBOUTS SA, BARKHOF F, VELTMAN DJ et al. (2000). Functional MR imaging in Alzheimer's disease during memory encoding. AJNR Am J Neuroradiol, 21: 1869-1875.
25. ROMBOUTS SARB, GOEKOOP R, BARKHOF F, SCHELTENS P. (2005a). Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease. Neuroimage, 26: 1078-1085.
26. ROMBOUTS SARB, BARKHOF F, GOEKOOP R, SCHELTENS P. (2005b). Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study. Hum Brain Mapp, 26: 231-239.
27. SAYKIN AJ, WISHART HA, RABIN LA et al. (2004). Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain, 127: 1574-1583.
28. SAYKIN AJ, FLASHMAN LA, FRUTIGER SA et al. (1999). Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation. J Int Neuropsychol Soc, 5: 377-392.
29. SCHEFF SW, PRICE DA, SCHMITT FA, MUFSON EJ. (2005). Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging, publication électronique.
30. SELKOE DJ. (2002). Alzheimer's disease is a synaptic failure. Science, 298: 789-791.
31. SMALL SA, PERERA GM, DELAPAZ R, MAYEUX R, STERN Y. (1999). Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol, 45: 466-472.
32. SMITH CD, ANDERSEN AH, KRYSCIO RJ et al. (2002). Women at risk for AD show increased parietal activation during a fluency task. Neurology, 58: 1197-1202.
33. SPERLING R, CHUA E, COCCHIARELLA A et al. (2003a). Putting names to faces: successful encoding of associative memories activates the anterior hippocampal formation. Neuroimage, 20: 1400-1410.
34. SPERLING R, GREVE D, DALE A et al. (2002). Functional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci U S A, 99: 455-460.
35. SPERLING RA, BATES JF, CHUA EF et al. (2003b). fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry, 74: 44-50.
36. THIEL CM, HENSON RN, DOLAN RJ. (2002). Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study. Neuropsychopharmacology, 27: 282-292.
37. THULBORN KR, MARTIN C, VOYVODIC JT. (2000). Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers. AJNR Am J Neuroradiol, 21: 524-531.
38. TRINH NH, HOBLYN J, MOHANTY S, YAFFE K. (2003). Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. Jama, 289: 210-216.